The Compounding Trap: Why Yesterday's Winners Wreck Tomorrow's Portfolio

The Compounding Trap: Why Yesterday's Winners Wreck Tomorrow's Portfolio

A question is circulating this week: "If you'd invested $1,000 in SMH 10 years ago, here's how much you'd have today." The answer is eye-watering. It's the kind of headline that makes people regret every day they didn't go all-in on semiconductors in 2016.

Then Nvidia slides on AI spending fears. Tesla announces another solar deal in Texas. SpaceX loses $1.2 trillion in market value after a valuation collapse. And the same investors who mentally counted their phantom SMH gains are now watching them evaporate.

This is not a bug in how we think about investing. It's a feature. And it will cost you real money if you don't understand it.

The Backtest Seduction

The "$1,000 in SMH" article is mathematically true. It's also the most dangerous form of honesty. Here's why: that $1,000 would have required you to own the exact basket that SMH holds today, rebalanced the exact way it rebalances, through exactly the two drawdowns the sector endured in 2022 and 2023.

Most people who bought chip stocks a decade ago did not own SMH. They owned a brokerage account with three or four holdings. They sold some during the 2018 correction. They added more in 2020 and panicked in 2022. They chased the hot name and let the laggards rot in their portfolio.

That's not backtest performance. That's real life. And real life is messier.

The Real Lesson From This Week's Headlines

The chip stocks didn't get smarter. The companies didn't suddenly become better operators. What changed is that the market repriced them. Nvidia is being punished not because it failed, but because the acceleration in AI capex is slowing. Tesla's solar deals in Arizona and Texas are real, but they don't change the fact that the stock's P/E ratio is stretched. SpaceX was valued like a private-equity lottery ticket until it wasn't.

Concentration in winners works until it doesn't. And the market tells you when that moment is coming. It just doesn't tell you very far in advance.

Meanwhile, SCHD versus VIG is the question nobody asks until they're down 30% from a market peak. SCHD buys dividend payers with higher yields. VIG buys dividend growers with lower current yields. Over the past 10 years, this is a blowout: growth won. But growth always wins in bull markets. The question is what wins after the repricing.

The Practical Money Lesson

Stop asking which asset class won the last 10 years. Start asking which assets are priced rationally for the next 5. SpaceX losing $1.2 trillion in private-market valuation is not a disaster. It's a repricing toward reality. When private markets finally match public markets in honesty, that's often when public investors stop overpaying.

Tesla buying power from solar projects is sound strategy. It's also fully priced into the stock already. The company's worth something, but not everything.

The dangerous investing pattern is this: you chase the backtest, you catch the stock after it's already risen, you hold it because the story is still intact, you sell it after the drawdown has already started. Then you read the next "$1,000 in X" headline and repeat.

The bottom line

Past performance in concentrated bets blinds you to current risk. The chips that crushed it for 10 years didn't suddenly become bad businesses. They became expensive ones. Buy diversified exposure, rebalance when weights drift, and stop chasing the backtests.

You can explore how the strongest dividend growers and dividend payers stack up on SteadyShares' dividend screener.

This is educational information, not financial advice.